TAAV
Gene therapy, gene therapy, biotechnology, biotechnology, biomanufacturing, enzymatic, synthetic, enzymatic, synthetic, DNA, DNA, synthetic DNA, enzymatic DNA, alternative to plasmid, AAV, rAAV, adeno-associated viruses, partner, CDMO, AAV manufacturing. TAAV Biomanufacturing Solutions, SLU (TAAV), a wholly owned subsidiary of Asklepios Biopharmaceuticals (AskBio) and Bayer AG, manufactures enzymatic DNA for the production of recombinant adeno-associated viruses (rAAVs)…